Molecular Insight Pharmaceuticals, Inc. Sample Contracts

RECITALS:
Stock Purchase Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
Sample 1Sample 2Sample 3See All (1k)
AutoNDA by SimpleDocs
WITNESSETH:
License Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Sample 1Sample 2Sample 3See All (1k)
EXHIBIT 10.24 THIS AGREEMENT made in duplicate as of the 22 day of March, 2006, BETWEEN: MDS NORDION, a division of MDS (Canada) Inc. a corporation incorporated under the laws of Canada having a place of business at 447 March Road, Kanata, Ontario,...
Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Sample 1Sample 2Sample 3See All (650)
RECITALS:
Securities Purchase Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (594)
EXHIBIT 10.27 LICENSE AGREEMENT
License Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Basel-Stadt
Sample 1Sample 2Sample 3See All (498)
DEFINITIONS
License Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Sample 1Sample 2Sample 3See All (386)
RECITALS:
Registration Rights Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
Sample 1Sample 2Sample 3See All (377)
WITNESSETH:
Employment Agreement • April 2nd, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Sample 1Sample 2Sample 3See All (309)
RECITALS:
Investor Rights Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
Sample 1Sample 2Sample 3See All (292)
RECITALS:
Registration Rights Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (289)
TEN COM - as tenants in common UNIF GIFT MIN ACT- ____________ Custodian ____________ TEN ENT - as tenants by the (Cust) (Minor) entireties JT TEN - as joint tenants with under Uniform Gifts to Minors right of survivorship Act ________________ and not...
Molecular Insight Pharmaceuticals, Inc. • January 22nd, 2007 • Pharmaceutical preparations

transferable on the books of the Corporation by the holder hereof in person or by duly authorized Attorney, upon surrender of this Certificate, properly endorsed. This Certificate and the shares represented hereby are issued under and shall be held subject to the laws of the Commonwealth of Massachusetts and the Articles of Organization and By-Laws of the Corporation and all amendments thereto, copies of which are on file with the Transfer Agent, to all of which the holder of this Certificate assents by acceptance hereof.

Sample 1Sample 2Sample 3See All (228)
Exhibit 10.34 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...
Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Sample 1Sample 2Sample 3See All (219)
Exhibit 10.3 AMENDED AND RESTATED VOTING AGREEMENT THIS AMENDED AND RESTATED VOTING AGREEMENT is dated as of March 29, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Company"), the holders of the Company's...
Voting Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Sample 1Sample 2Sample 3See All (207)
First Amendment
License Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Sample 1Sample 2Sample 3See All (188)
MDS NORDION, a division of MDS (Canada) Inc. having a place of business at 447 March Road Ottawa, Ontario, Canada K2K1X8 ("Nordion")
Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Sample 1Sample 2Sample 3See All (134)
Exhibit 10.36 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...
Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Sample 1Sample 2Sample 3See All (118)
Exhibit 10.37 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...
Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Sample 1Sample 2Sample 3See All (101)
EXHIBIT 10.30 TECHNOLOGY TRANSFER AGREEMENT THIS TECHNOLOGY TRANSFER AGREEMENT (the "Agreement") is entered into effective as of the 20th day of December 2006 (the "Effective Date"), by and between Mallinckrodt Inc., a Delaware corporation, with a...
Technology Transfer Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Sample 1Sample 2Sample 3See All (52)
1. BACKGROUND
Exclusive License Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • District of Columbia
Sample 1Sample 2Sample 3See All (15)
WITNESSETH:
Employment Agreement • January 19th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Sample 1Sample 2Sample 3See All (12)
WITNESSETH:
Employment Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Sample 1Sample 2Sample 3See All (8)
BACKGROUND
License, Development and Commercialization Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
RECITALS:
Contract of Purchase and Sale • May 17th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
Sample 1Sample 2Sample 3
INVESTMENT AGREEMENT dated as of December 9, 2010 between MOLECULAR INSIGHT PHARMACEUTICALS, INC. and SAVITR CAPITAL LLC
Investment Agreement • December 14th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

THIS INVESTMENT AGREEMENT (together with all exhibits and schedules hereto and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms hereof, the “Agreement”), dated as of December 9, 2010, by and among Savitr Capital LLC, a Delaware limited liability company (the “Investor”) and Molecular Insight Pharmaceuticals, a Massachusetts corporation (the “Company”) and its successors, including, as the context may require, on or after the Effective Date, as reorganized pursuant to the Bankruptcy Code.

Sample 1Sample 2
CHANGE OF CONTROL AGREEMENT
Change of Control Agreement • March 26th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts

This CHANGE OF CONTROL AGREEMENT, made as of March 22, 2010, is by and between Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Company”), and Charles H. Abdalian, Jr. (the “Employee”). All references to the Company include all affiliated or subsidiary entities including, without limitation, a Buyer in a Change of Control (each as defined below).

Sample 1Sample 2
and
Unit Purchase Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Sample 1Sample 2
GREENWORKS MOLECULAR INSIGHT PHARMACEUTICALS LEASE
Greenworks Molecular • May 8th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Sample 1
SEVENTH AMENDMENT TO MOLECULAR INSIGHT PHARMACEUTICALS, INC., GREENWORKS LEASE
Molecular Insight Pharmaceuticals, Inc. • January 25th, 2008 • Pharmaceutical preparations

For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, RayJoe Limited Partnership (“Landlord”) and Molecular InSight Pharmaceuticals, Inc., (“Tenant”), confirm the following facts and their agreement as follows:

Sample 1
EMPLOYMENT AGREEMENT (for Donald Wallroth)
Employment Agreement • September 11th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts

THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of August 13, 2007 (the “Effective Date”), is made by and between Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation having its principal place of business at 160 Second Street, Cambridge, Massachusetts 02142 (the “Employer”), and Donald Wallroth (the “Employee”).

Sample 1
LEASE AGREEMENT
Lease Agreement • May 8th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS LEASE AGREEMENT (the “Lease”) is dated as of April 25, 2008, between ARE-MA REGION NO. 35, LLC, a Delaware limited liability company (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation (“Tenant”).

Sample 1
SECOND AMENDMENT TO LEASE
Lease • May 6th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations

This Second Amendment to Lease (the “Second Amendment”) is made as of March 30, 2010, by and between ARE-MA REGION NO. 35, LLC, a Delaware limited liability company, having an address at 385 East Colorado Boulevard, Suite 299, Pasadena, CA 91101 (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation, having an address at 160 Second Street, Cambridge, MA 02142 (“Tenant”).

Sample 1
Exhibit 10.20 MOLECULAR INSIGHT PHARMACEUTICALS CONSULTING AGREEMENT 1. INTRODUCTION. This Agreement is made by and between William C. Eckelman, Ph.D., ("Consultant"), with offices at 10432 Snow Point Drive, Bethesda, MD 20814, and Molecular Insight...
Consulting Agreement • January 19th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Sample 1
PLEDGE AND SECURITY AGREEMENT dated as of November 16, 2007 Among THE ENTITIES LISTED ON SCHEDULE A HERETO, as Pledgors and THE BANK OF NEW YORK TRUST COMPANY, N.A., as Collateral Agent
Pledge and Security Agreement • November 16th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations

In consideration of the purchase of the Bonds (as hereinafter defined) issued under the Indenture by and among Molecular Insight Pharmaceuticals, Inc. and The Bank of New York Trust Company, N.A., as Trustee, Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation and each of the Subsidiary Guarantors party from time to time thereto (each a “Pledgor” and collectively the “Pledgors”) hereby agree with The Bank of New York Trust Company, N.A., as Collateral Agent, as follows (with certain terms used herein being defined in Article 7):

Sample 1
FIRST AMENDMENT TO LEASE AND ACKNOWLEDGMENT OF COMMENCEMENT DATE
Molecular Insight Pharmaceuticals, Inc. • May 6th, 2010 • Pharmaceutical preparations

This First Amendment to Lease and Acknowledgment of Commencement Date (the “First Amendment”) is made as of June 3, 2008, by and between ARE-MA REGION 35, LLC, a Delaware limited liability company, having an address at 385 East Colorado Boulevard, Suite 299, Pasadena, California 91101 (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation, having an address at 160 Second Street, Cambridge, Massachusetts 02142 (“Tenant”).

Sample 1
Common Stock
Molecular Insight Pharmaceuticals, Inc. • January 25th, 2007 • Pharmaceutical preparations • New York
Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.